These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 21605180

  • 1. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
    Schulz B, Weber K, Schmidt A, Borg-von Zepelin M, Ruhnke M.
    Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA, Paula CR.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
    González GM, Robledo E, Saldívar D, González G, Bosques F, Garza E.
    Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
    [Abstract] [Full Text] [Related]

  • 8. Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
    Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P.
    J Antimicrob Chemother; 2012 Sep; 67(9):2131-8. PubMed ID: 22678731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C, González P, Pereira A, Pérez J, Noriega LM, Palavecino E.
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Study on experimental induction of fluconazole resistance in Candida albicans].
    Zhu YN, Lu SM.
    Shi Yan Sheng Wu Xue Bao; 2004 Oct; 37(5):418-22. PubMed ID: 15636370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M, López-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, Ruesga MT, Patterson TF.
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Bozó A, Domán M, Majoros L, Kardos G, Varga I, Kovács R.
    J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.